Multidomain therapy for Alzheimer's disease: a scoping review of cognitive decline trials.

Publication Title

Mol Neurodegener

Authors

Jared C Roach, Institute for Systems Biology, Seattle, WA USAFollow
Gwênlyn Glusman, Institute for Systems Biology, Seattle, WA USA
Molly K Rapozo, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
David A Merrill, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
Jennifer Bramen, Pacific Neuroscience Institute, Santa Monica, CA, USA, Saint John's Cancer Institute, Santa Monica, CA, USA.Follow
John F Hodes, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
Prabha Siddarth, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
Somayeh Meysami, Pacific Neuroscience Institute, Santa Monica, CA, USA, Saint John's Cancer Institute, Santa Monica, CA, USA.Follow
Shannel H K Elhelou, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
Ryan M Glatt, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
Lance Edens, Institute for Systems Biology, Seattle, WA USA
Cory Funk, Institute for Systems Biology, Seattle, WA USA
Dan Kelly, Pacific Neuroscience Institute, Santa Monica, CA, USA
William R Shankle
Dale Bredesen, Pacific Neuroscience Institute, Santa Monica, CA, USA
Cyrus A Raji
Leroy Hood, Institute for Systems Biology, Seattle, WA USAFollow

Document Type

Article

Publication Date

11-22-2025

Keywords

washington; isb; california; pni; pacific neurosci

Area of Special Interest

Neurosciences (Brain & Spine)

Area of Special Interest

Mental Health

Specialty/Research Institute

Neurosciences

Specialty/Research Institute

Behavioral Health

DOI

10.1186/s13024-025-00912-2